Serum profile of isosorbide mononitrate after vaginal administration in the third trimester

C.D. Bates, A.E. Nicoll, A.B. Mullen, F. Mackenzie, A.J. Thomson, J.E. Norman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Vaginally administered nitric oxide donors such as isosorbide mononitrate have been used to ripen the uterine cervix in pregnancy. The pharmacokinetics of isosorbide mononitrate following vaginal administration are unknown. Serum levels of isosorbide mononitrate were determined at baseline and 60, 180 and 360 minutes after vaginal administration of 20 or 40 mg isosorbide mononitrate to pregnant women scheduled for induction of labour at term. Serum levels of isosorbide mononitrate continued to rise up to 360 minutes after isosorbide mononitrate insertion, with mean (SD) final levels of 337 (94) g/L following isosorbide mononitrate 40 mg and 144 (47) g/L following isosorbide mononitrate 20 mg, P < 0.01 .
LanguageEnglish
Pages64-67
Number of pages3
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume110
Issue number1
DOIs
Publication statusPublished - Jan 2003

Fingerprint

isosorbide-5-mononitrate
Intravaginal Administration
Third Pregnancy Trimester
Serum
Induced Labor
Nitric Oxide Donors
Cervix Uteri
Pregnant Women

Keywords

  • obstetrics
  • gynaecology
  • isosorbide mononitrate

Cite this

Bates, C.D. ; Nicoll, A.E. ; Mullen, A.B. ; Mackenzie, F. ; Thomson, A.J. ; Norman, J.E. / Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. In: BJOG: An International Journal of Obstetrics and Gynaecology . 2003 ; Vol. 110, No. 1. pp. 64-67.
@article{ee3087006be0432782e7a1bbba58bccd,
title = "Serum profile of isosorbide mononitrate after vaginal administration in the third trimester",
abstract = "Vaginally administered nitric oxide donors such as isosorbide mononitrate have been used to ripen the uterine cervix in pregnancy. The pharmacokinetics of isosorbide mononitrate following vaginal administration are unknown. Serum levels of isosorbide mononitrate were determined at baseline and 60, 180 and 360 minutes after vaginal administration of 20 or 40 mg isosorbide mononitrate to pregnant women scheduled for induction of labour at term. Serum levels of isosorbide mononitrate continued to rise up to 360 minutes after isosorbide mononitrate insertion, with mean (SD) final levels of 337 (94) g/L following isosorbide mononitrate 40 mg and 144 (47) g/L following isosorbide mononitrate 20 mg, P < 0.01 .",
keywords = "obstetrics, gynaecology, isosorbide mononitrate",
author = "C.D. Bates and A.E. Nicoll and A.B. Mullen and F. Mackenzie and A.J. Thomson and J.E. Norman",
note = "contact email not found",
year = "2003",
month = "1",
doi = "10.1046/j.1471-0528.2003.02004.x",
language = "English",
volume = "110",
pages = "64--67",
journal = "BJOG: An International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
number = "1",

}

Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. / Bates, C.D.; Nicoll, A.E.; Mullen, A.B.; Mackenzie, F.; Thomson, A.J.; Norman, J.E.

In: BJOG: An International Journal of Obstetrics and Gynaecology , Vol. 110, No. 1, 01.2003, p. 64-67.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum profile of isosorbide mononitrate after vaginal administration in the third trimester

AU - Bates, C.D.

AU - Nicoll, A.E.

AU - Mullen, A.B.

AU - Mackenzie, F.

AU - Thomson, A.J.

AU - Norman, J.E.

N1 - contact email not found

PY - 2003/1

Y1 - 2003/1

N2 - Vaginally administered nitric oxide donors such as isosorbide mononitrate have been used to ripen the uterine cervix in pregnancy. The pharmacokinetics of isosorbide mononitrate following vaginal administration are unknown. Serum levels of isosorbide mononitrate were determined at baseline and 60, 180 and 360 minutes after vaginal administration of 20 or 40 mg isosorbide mononitrate to pregnant women scheduled for induction of labour at term. Serum levels of isosorbide mononitrate continued to rise up to 360 minutes after isosorbide mononitrate insertion, with mean (SD) final levels of 337 (94) g/L following isosorbide mononitrate 40 mg and 144 (47) g/L following isosorbide mononitrate 20 mg, P < 0.01 .

AB - Vaginally administered nitric oxide donors such as isosorbide mononitrate have been used to ripen the uterine cervix in pregnancy. The pharmacokinetics of isosorbide mononitrate following vaginal administration are unknown. Serum levels of isosorbide mononitrate were determined at baseline and 60, 180 and 360 minutes after vaginal administration of 20 or 40 mg isosorbide mononitrate to pregnant women scheduled for induction of labour at term. Serum levels of isosorbide mononitrate continued to rise up to 360 minutes after isosorbide mononitrate insertion, with mean (SD) final levels of 337 (94) g/L following isosorbide mononitrate 40 mg and 144 (47) g/L following isosorbide mononitrate 20 mg, P < 0.01 .

KW - obstetrics

KW - gynaecology

KW - isosorbide mononitrate

UR - http://www3.interscience.wiley.com

UR - http://dx.doi.org/10.1046/j.1471-0528.2003.02004.x

U2 - 10.1046/j.1471-0528.2003.02004.x

DO - 10.1046/j.1471-0528.2003.02004.x

M3 - Article

VL - 110

SP - 64

EP - 67

JO - BJOG: An International Journal of Obstetrics and Gynaecology

T2 - BJOG: An International Journal of Obstetrics and Gynaecology

JF - BJOG: An International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 1

ER -